Eran Elinav, MD, PhD
Professor, Deutsches Krebsforschungszentrum (DKFZ) Weizmann Institute of Science, Current Grantee
The ElinavLab studies the interactions between the mammalian host and its microbiome to uncover effects on health and disease. They harness experimental biology, human trials and big data analyses to devise microbiome-based personalized medicine.
Charles O. Elson, MD
Professor, University of Alabama at Birmingham, Former Grantee
Dr. Elson’s lab focuses on the regulation of mucosal immune responses, particularly the mucosal immune response to the microbiota, to define the cellular and molecular mechanisms that maintain mucosal immune homeostasis.
Gregory Fairn, PhD
Professor, Dalhousie University, Former Grantee
The Fairn lab studies a variety of aspects related to vesicular and non-vesicular transport of lipids, lipid metabolism, membrane dynamics and the cell biology of immune cells.
Jeremiah Faith, PhD
Associate Professor, Icahn School of Medicine at Mount Sinai, Current Grantee
The Faith Lab is developing and applying experimental and computational tools to understand gut microbiota microbiota structure and function to develop live defined microbial therapeutics.
Emilia Favuzzi, PhD
Assistant Professor, Yale University, Current Grantee
Dr. Favuzzi’s lab is investigating how immune information is encoded within cortical circuits and on identifying the fundamental biological mechanisms underlying brain and behavioral disorders influenced by immune challenges.
Kate Fitzgerald, PhD
Professor, University of Massachusetts, Former Grantee
The Fitzgerald lab investigates the molecular mechanism controlling the innate immune response during infection and inflammation. They focus on therapeutic targeting of Inflammasomes and nucleic acid sensing pathways to treat inflammatory diseases.
